News

The new alliance will focus on the evaluation and further development of a radioligand discovered by AstraZeneca. This radioligand is a molecule that binds to amyloid plaque protein

Under the terms of the agreement this will trigger a major milestone payment from Meldex International in February 2008. Kerry Gray, president and CEO of Uluru, said: “I

Under the terms of the agreement, InSite grants exclusive rights to Shin Poong to commercialize AzaSite (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis treatment in Korea. Shin Poong

The new drug application (NDA) is supported by data from three open-label, multi-center, randomized phase III efficacy and safety clinical studies and a fourth phase III safety study.

The objective of this trial is to evaluate the anti-tumor activity of IPI-504 in patients with non-small cell lung cancer (NSCLC). Initially, the phase II portion of the

This trial is being sponsored by the National Cancer Institute (NCI) under a clinical trials agreement with CuraGen for belinostat. The primary objective of the study is to

The Multiple Myeloma Research Consortium (MMRC) collaboration is evaluating the preclinical activity of SNS-032 in multiple myeloma-relevant models and in primary disease tissue, extending non-clinical studies performed by

The participants in this clinical trial were randomized 1:1 in the treatment and placebo arms of the study titled, “randomized, single-blind, placebo-controlled study to evaluate the safety of

Genzyme believes that Synvisc-One will simplify osteoarthritis pain management and provide added patient convenience, while reducing the overall cost of therapy associated with multiple injections and offering a